Patrick Verschueren (P Verschueren)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 42

Top Venues

RMD open

Annals of the rheumatic diseases

The Journal of rheumatology

Rheumatology advances in practice

Universitaire Ziekenhuizen Leuven

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitaire Ziekenhuizen Leuven

Belgium

Head of Clinics :: Rheumatology

Katholieke Universiteit Leuven Faculteit Geneeskunde

Belgium

Professor :: Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration

Publications

Michaël Doumen, Elias De Meyst, Patrick Verschueren
Physician estimates of inflammation, damage and distress in rheumatoid arthritis: how can they be used to improve patient care? Rheumatology advances in practice 8 (3) (2024)
Delphine Bertrand, Johan Joly, Barbara Neerinckx, Patrick Durez, Jan Lenaerts, Rik Joos, Kristof Thevissen, Tom Zwaenepoel, Johan Vanhoof, Silvana Di Romana, Veerle Taelman, Els Van Essche, Luk Corluy, Clio Ribbens, Marc Vanden Berghe, Mieke Devinck, Sofia Ajeganova, Anne Durnez, Yves Boutsen, Joëlle Margaux, Isabelle Peene, Jan Van Offel, Michaël Doumen, Sofia Pazmino, Elias De Meyst, Myroslava Kulyk, Nelly Creten, René Westhovens, Patrick Verschueren, null null
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial. RMD open 10 (3) (2024)
Guenter Steiner, Patrick Verschueren, Lieve VAN Hoovels, Paul Studenic, Xavier Bossuyt
Classification of rheumatoid arthritis: is it time to revise the criteria? RMD open 10 (2) (2024)
Guenter Steiner, Patrick Verschueren, Lieve VAN Hoovels, Paul Studenic, Xavier Bossuyt
Classification of rheumatoid arthritis: is it time to revise the criteria? RMD open 10 (2) (2024)
Guenter Steiner, Patrick Verschueren, Lieve VAN Hoovels, Paul Studenic, Xavier Bossuyt
Classification of rheumatoid arthritis: is it time to revise the criteria? RMD open 10 (2) (2024)
Guenter Steiner, Patrick Verschueren, Lieve VAN Hoovels, Paul Studenic, Xavier Bossuyt
Classification of rheumatoid arthritis: is it time to revise the criteria? RMD open 10 (2) (2024)
Guenter Steiner, Patrick Verschueren, Lieve VAN Hoovels, Paul Studenic, Xavier Bossuyt
Classification of rheumatoid arthritis: is it time to revise the criteria? RMD open 10 (2) (2024)
Lieve VAN Hoovels, Liesbeth E Bakker-Jonges, Dina Vara, Caroline Bijnens, Lucy Studholme, Daniela Sieghart, Bert Vander Cruyssen, Patrick Verschueren, Guenter Steiner, Jan G M C Damoiseaux, Xavier Bossuyt
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens. Annals of the rheumatic diseases (2024)
Michaël Doumen, Elias De Meyst, Patrick Verschueren
Physician estimates of inflammation, damage and distress in rheumatoid arthritis: how can they be used to improve patient care? Rheumatology advances in practice 8 (3) (2024)
Marianne A Messelink, Alfons A den Broeder, Florine E Marinelli, Edwin Michgels, Patrick Verschueren, Daniel Aletaha, Janneke Tekstra, Paco M J Welsing
What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis. RMD open 9 (2) (2023)
René Westhovens, Patrick Verschueren
Lessons from negative phase 3 trials in rheumatoid arthritis anno 2023. Annals of the rheumatic diseases (2023)
Marianne A Messelink, Alfons A den Broeder, Florine E Marinelli, Edwin Michgels, Patrick Verschueren, Daniel Aletaha, Janneke Tekstra, Paco M J Welsing
What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis. RMD open 9 (2) (2023)
Alejandro Balsa, Siegfried Wassenberg, Yoshiya Tanaka, Anne Tournadre, Hans-Dieter Orzechowski, Vijay Rajendran, Udo Lendl, Pieter-Jan Stiers, Chris Watson, Roberto Caporali, James B Galloway, Patrick Verschueren
Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis. Rheumatology and therapy (2023)
Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Annals of the rheumatic diseases (2023)
Marianne A Messelink, Alfons A den Broeder, Florine E Marinelli, Edwin Michgels, Patrick Verschueren, Daniel Aletaha, Janneke Tekstra, Paco M J Welsing
What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis. RMD open 9 (2) (2023)
Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, Rieke E Alten, Katerina Chatzidionysiou, James B Galloway, John Isaac, Denis Mulleman, Patrick Verschueren, Arnold G Vulto, Paco M J Welsing, Lise Verhoef, Alfons A den Broeder
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. RMD open 9 (1) (2023)
Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, Rieke E Alten, Katerina Chatzidionysiou, James B Galloway, John Isaac, Denis Mulleman, Patrick Verschueren, Arnold G Vulto, Paco M J Welsing, Lise Verhoef, Alfons A den Broeder
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. RMD open 9 (1) (2023)
Marianne A Messelink, Alfons A den Broeder, Florine E Marinelli, Edwin Michgels, Patrick Verschueren, Daniel Aletaha, Janneke Tekstra, Paco M J Welsing
What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis. RMD open 9 (2) (2023)
Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, Rieke E Alten, Katerina Chatzidionysiou, James B Galloway, John Isaac, Denis Mulleman, Patrick Verschueren, Arnold G Vulto, Paco M J Welsing, Lise Verhoef, Alfons A den Broeder
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. RMD open 9 (1) (2023)
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Diederik De Cock, Lene Dreyer, Ori Elkayam, Doreen Huschek, Kimmie L Hyrich, Florenzo Iannone, Güzide Nevsun İnanç, Lianne Kearsley-Fleet, Suleyman Serdar Koca, Tore K Kvien, Burkhard F Leeb, Galina Lukina, Dan C Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ana Rodrigues, Ziga Rotar, Anja Strangfeld, Patrick Verschueren, Rasmus Westermann, Jakub Zavada, Delphine Sophie Courvoisier, Axel Finckh, Kim Lauper
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study). Annals of the rheumatic diseases (2023)
Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, Rieke E Alten, Katerina Chatzidionysiou, James B Galloway, John Isaac, Denis Mulleman, Patrick Verschueren, Arnold G Vulto, Paco M J Welsing, Lise Verhoef, Alfons A den Broeder
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. RMD open 9 (1) (2023)
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert B M Landewe, Johannes Jw Bijlsma, Andreas Kerschbaumer, René Westhovens, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases 81 (7) (2022)
Lotte van Ouwerkerk, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Patrick Verschueren, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Lieve VAN Hoovels, Lucy Studholme, Bert Vander Cruyssen, Daniela Sieghart, Carolien Bonroy, Eszter Nagy, Rille Pullerits, Sasa Čučnik, Charlotte Dahle, Ingmar Heijnen, Luca Bernasconi, Farid Benkhadra, Laura Bogaert, Stefanie Van Den Bremt, Ann Van Liedekerke, Geert Vanheule, Johan Robbrecht, Claudine Wirth, Rüdiger Müller, Diego Kyburz, Christopher Sjöwall, Alf Kastbom, Rok Ješe, Boja Jovancevic, Emese Kiss, Peggy Jacques, Daniel Aletaha, Günter Steiner, Patrick Verschueren, Xavier Bossuyt
Standardisation of ACPA tests: evaluation of a new candidate reference preparation. Annals of the rheumatic diseases (2022)
Sofia Pazmino, Anikó Lovik, René Westhovens, Patrick Verschueren, null null
Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication. The Journal of rheumatology 49 (4) (2022)
Jean-Baptiste Vulsteke, Yves Piette, Carolien Bonroy, Patrick Verschueren, Daniel Blockmans, Steven Vanderschueren, Kristl G Claeys, Petra De Haes, Jan Leo Lenaerts, Wim A Wuyts, Takashi Matsushita, Vanessa Smith, Ellen De Langhe, Xavier Bossuyt
Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern. Annals of the rheumatic diseases 81 (5) (2022)
Sofia Pazmino, Patrick Verschueren, René Westhovens
JAK inhibition and the holy grail for pain control in early RA. RMD open 8 (1) (2022)
Lieve VAN Hoovels, Bert Vander Cruyssen, Daniela Sieghart, Carolien Bonroy, Eszter Nagy, Rille Pullerits, Saša Čučnik, Charlotte Dahle, Ingmar Heijnen, Luca Bernasconi, Farid Benkhadra, Laura Bogaert, Stefanie Van Den Bremt, Ann Van Liedekerke, Geert Vanheule, Johan Robbrecht, Lucy Studholme, Claudine Wirth, Ruediger B Mueller, Diego Kyburz, Christopher Sjöwall, Alf Kastbom, Rok Ješe, Boja Jovancevic, Emese Kiss, Peggy Jacques, Daniel Aletaha, Guenter Steiner, Patrick Verschueren, Xavier Bossuyt
Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results. RMD open 8 (1) (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Désirée Mfm van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Josef S Smolen, Robert B M Landewe
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S Smolen, Désirée Mfm van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Robert B M Landewe
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Michaël Doumen, Sofia Pazmino, Delphine Bertrand, Diederik De Cock, Johan Joly, René Westhovens, Patrick Verschueren
Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response. Annals of the rheumatic diseases 81 (10) (2022)
Michaël Doumen, Diederik De Cock, Caroline Van Lierde, Albrecht Betrains, Sofia Pazmino, Delphine Bertrand, René Westhovens, Patrick Verschueren
Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis. RMD open 8 (2) (2022)
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée Mfm van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Robert B M Landewe
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Kim Lauper, Michele Iudici, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, René Cordtz, Diederik De Cock, Lene Dreyer, Ori Elkayam, Ellen-Margrethe Hauge, Doreen Huschek, Kimmie L Hyrich, Florenzo Iannone, Nevsun Inanc, Lianne Kearsley-Fleet, Eirik Klami Kristianslund, Tore K Kvien, Burkhard F Leeb, Galina Lukina, Dan C Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria Jose Santos, Anja Strangfeld, Patrick Verschueren, Delphine Sophie Courvoisier, Axel Finckh
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration. Annals of the rheumatic diseases 81 (10) (2022)
Kristien Van der Elst, Diederik De Cock, Lore Bangels, Lianne Peerlings, Michael Doumen, Delphine Bertrand, Lies De Caluwé, Ilse Langers, Veerle Stouten, René Westhovens, Patrick Verschueren
'More than just chitchat': a qualitative study concerning the need and potential format of a peer mentor programme for patients with early rheumatoid arthritis. RMD open 7 (3) (2021)
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir et al. Annals of the rheumatic diseases (2021)
Diederik De Cock, Sofia Pazmino, S Pazmino, Delphine Bertrand, Veerle Stouten, René Westhovens, Patrick Verschueren
Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study. Rheumatology international (2021)
Veerle Stouten, Sofia Pazmino, Patrick Verschueren, Pavlos Mamouris, René Westhovens, Kurt de Vlam, Delphine Bertrand, Kristien Van der Elst, Bert Vaes, Diederik De Cock
Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study. RMD open 7 (2) (2021)
Sofia Pazmino, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, René Westhovens, Patrick Verschueren
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial. RMD open 7 (2) (2021)
Sofia Pazmino, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren
Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden? The Journal of rheumatology 48 (2) (2020)
Rachelle Meisters, Polina Putrik, Josef S Smolen, Monika Hifinger, Andras P Keszei, Yvonne van Eijk-Hustings, Anthony D Woolf, Josef S Smolen, Tanja Alexandra Stamm, Michaela Stoffer-Marx, Till Uhlig, Rikke Helene Moe, Maarten P T de Wit, Argjend Tafaj, Vahan Mukuchyan, Paul Studenic, Patrick Verschueren, Russka Shumnalieva, Paraskevi Charalambous, Jiří Vencovský, Melpomeni Varvouni, Mart Kull, Kari Puolakka, Laure Gossec, Nino Gobejishvili, Jacqueline Detert, Prodromos Sidiropoulos, Márta Péntek, David Kane, And Carlo Alberto Scirè, Uri Arad, Daina Andersone, Mart van de Laar, Annette H M van der Helm van Mil, Piotr Głuszko, Luís Cunha-Miranda, Florian Berghea, Nemanja S Damjanov, Matija Tomšič, Loreto Carmona, Carl Turesson, Adrian Ciurea, Surayo Shukurova, Güzide Nevsun İnanç, Suzanne Mm Verstappen, Annelies Boonen, null null
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries. Annals of the rheumatic diseases 79 (11) (2020)

Patrick Verschueren.css-eqlu8i{font-size:small;padding-left:4px;} (P Verschueren)

Publication Activity (10 Years)

Top Topics

Top Venues

Patrick Verschueren (P Verschueren)